Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostate Adenocarcinoma × Genitourinary × Clear all

Phase

Phase 2 16 Phase NA 10 Phase 1 6 Phase 3 3 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 378 Carcinoma, Renal Cell 208 Urinary Bladder Neoplasms 116 Carcinoma, Non-Small-Cell Lung 99 Melanoma 78 Carcinoma, Transitional Cell 73 Ovarian Neoplasms 71 Neoplasm Metastasis 71 Kidney Neoplasms 71 Breast Neoplasms 68 Neoplasms 64 Colorectal Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 50 Stomach Neoplasms 49 Uterine Cervical Neoplasms 44 Pancreatic Neoplasms 44 Triple Negative Breast Neoplasms 39 Lung Neoplasms 35 Esophageal Neoplasms 32 Non-Muscle Invasive Bladder Neoplasms 31 Endometrial Neoplasms 30 Carcinoma, Hepatocellular 29 Sarcoma 28 Small Cell Lung Carcinoma 25 Head and Neck Neoplasms 25 Colonic Neoplasms 19 Wilms Tumor 15 Metastatic Castration-resistant Prostate Cancer 14 Glioblastoma 14 Carcinoma, Merkel Cell 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02031328 2020-11-24

2STAR

Sunnybrook Health Sciences Centre

Phase 1/2 Unknown

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡